The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2

Gemma E. Hartley; Emily S.J. Edwards; Nirupama Varese; Irene Boo; Pei M. Aui; Scott J. Bornheimer; P. Mark Hogarth; Heidi E. Drummer; Robyn E. O'Hehir; Menno C. van Zelm

doi:10.1111/all.15624

The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2

Gemma E. Hartley, Emily S.J. Edwards, Nirupama Varese, Irene Boo, Pei M. Aui, Scott J. Bornheimer, P. Mark Hogarth, Heidi E. Drummer, Robyn E. O'Hehir, Menno C. van Zelm

Research output: Contribution to journal › Letter › Other › peer-review

1 Citation (Scopus)

Original language	English
Number of pages	3
Journal	Allergy
DOIs	https://doi.org/10.1111/all.15624
Publication status	Accepted/In press - Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/all.15624Licence: CC BY-NC-ND

Cite this

@article{91c06f07b0e04f2ca82f687d747fe9a9,

title = "The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2",

author = "Hartley, {Gemma E.} and Edwards, {Emily S.J.} and Nirupama Varese and Irene Boo and Aui, {Pei M.} and Bornheimer, {Scott J.} and Hogarth, {P. Mark} and Drummer, {Heidi E.} and O'Hehir, {Robyn E.} and {van Zelm}, {Menno C.}",

note = "Funding Information: We thank Dr. Bruce D. Wines and Ms. Sandra Esparon (Burnet Institute) for technical assistance, Mr. Jack Edwards and Ms. Ebony Blight (Monash University) for sample collection and preparation, and the staff of ARAFlowCore for flow cytometry support. Supported by an Australian Government Medical Research Future Fund (MRFF, Project no. 2016108; MCvZ, HED, and REO'H) and an unrestricted research grant from BD Biosciences. Open access publishing facilitated by Monash University, as part of the Wiley ‐ Monash University agreement via the Council of Australian University Librarians. ",

year = "2022",

month = dec,

doi = "10.1111/all.15624",

language = "English",

journal = "Allergy",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2

AU - Hartley, Gemma E.

AU - Edwards, Emily S.J.

AU - Varese, Nirupama

AU - Boo, Irene

AU - Aui, Pei M.

AU - Bornheimer, Scott J.

AU - Hogarth, P. Mark

AU - Drummer, Heidi E.

AU - O'Hehir, Robyn E.

AU - van Zelm, Menno C.

N1 - Funding Information: We thank Dr. Bruce D. Wines and Ms. Sandra Esparon (Burnet Institute) for technical assistance, Mr. Jack Edwards and Ms. Ebony Blight (Monash University) for sample collection and preparation, and the staff of ARAFlowCore for flow cytometry support. Supported by an Australian Government Medical Research Future Fund (MRFF, Project no. 2016108; MCvZ, HED, and REO'H) and an unrestricted research grant from BD Biosciences. Open access publishing facilitated by Monash University, as part of the Wiley ‐ Monash University agreement via the Council of Australian University Librarians.

PY - 2022/12

Y1 - 2022/12

UR - http://www.scopus.com/inward/record.url?scp=85145327665&partnerID=8YFLogxK

U2 - 10.1111/all.15624

DO - 10.1111/all.15624

M3 - Letter

C2 - 36541822

AN - SCOPUS:85145327665

SN - 0105-4538

JO - Allergy

JF - Allergy

ER -

The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2

UN SDGs

Access to Document

Other files and links

Cite this